Back |
home / stock / loxo / loxo message board
Subject | By | Source | When |
---|---|---|---|
A formal $LOXO-195 IND was recently cleared by | FooBarAndGrill | investorshub | 06/05/2017 5:29:24 PM |
The Cancer Discovery research brief provides early but | FooBarAndGrill | investorshub | 06/05/2017 5:28:43 PM |
$LOXO-195 was designed to address anticipated mechanisms of | FooBarAndGrill | investorshub | 06/05/2017 5:27:42 PM |
This publication highlights the potential for $LOXO-195 to | FooBarAndGrill | investorshub | 06/05/2017 5:26:28 PM |
Loxo Oncology Announces Clinical Proof of Concept Publication | FooBarAndGrill | investorshub | 06/05/2017 5:24:57 PM |
LOXO on CNBC. Exciting news! | FooBarAndGrill | investorshub | 06/05/2017 4:37:14 PM |
Loxo Oncology (LOXO +5.28%) fell over 3% in | jones99 | investorshub | 01/06/2017 10:45:12 AM |
$LOXO *DJ Loxo Oncology Announces EMA Orphan Drug | jones99 | investorshub | 01/15/2016 11:53:46 AM |
Eyeing this oncology stock as my top biotech | edge | investorshub | 01/02/2016 8:50:24 PM |
agraff04 | investorshub | 06/15/2015 7:13:43 PM | |
$LOXO recent news/filings | stocktrademan | investorshub | 06/14/2015 1:58:05 AM |
News, Short Squeeze, Breakout and More Instantly...
INDIANAPOLIS and STAMFORD, Conn. , Feb. 1, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) ("Lilly") and Loxo Oncology, Inc. (NASDAQ: LOXO) ("Loxo Oncology") today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 197...